Shah, E., Naqvi, S. M. A., Tariq, S. M., Saini, M., Tu, S. (2026). Real-world comparative outcomes of abiraterone vs enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC): A propensity-matched analysis from the TriNetX Global Health Research Network.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.124